Zn-DTPA administered by slow-release implant.
暂无分享,去创建一个
[1] C. W. Mays,et al. Teratological studies of Zn-DTPA in mice. , 1977, Health Physics.
[2] L. Ohlenschläger. Efficacy of Zn-DTPA in removing plutonium from the human body. , 1976, Health physics.
[3] R. D. Lloyd,et al. DTPA therapy of 241Am from a simulated wound site. , 1975, Health physics.
[4] C. W. Mays,et al. Ca-DTPA toxicity in the mouse fetus. , 1975, Health physics.
[5] H. Ebel,et al. Dependence of DTPA-toxicity on the treatment schedule. , 1975, Health Physics.
[6] C. W. Mays,et al. Decorporation of 241Am in beagles by DTPA. , 1975, Radiation Research.
[7] Roy C. Thompson,et al. Teratologic effectiveness and fetal toxicity of DTPA in the rat , 1975 .
[8] D. R. Atherton,et al. Increased toxicity of Na3CaDTP when given by protracted administration. , 1974, Health physics.
[9] V. Volf,et al. Decorporation of 239Pu and 241Am in the rat and hamster by Zn-DTPA. , 1974, Radiation research.
[10] R. Thompson,et al. Distribution and retention of inhaled DTPA , 1974 .
[11] M. Weiner,et al. Metabolism of the Chelating Agent Diethylenetriamine Pentaacetic Acid (C14DTPA) in Man.∗ , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.